Last update Sept. 2, 2021

Цефуроксим

Compatible

Safe product and/or breastfeeding is the best option.

Second-generation cephalosporin for oral or parenteral administration in two daily doses.

Like most cephalosporins for which data are available, excretion occurs in breast milk in very small amount and it is clinically insignificant (Kiriazopoulos 2017, Nakamura 1987, Amiraslanova 1985, Voropaeva 1982).
No problems have been observed in infants whose mothers have taken it (Benyamini 2005).

Intravenously administered Cefuroxime salt is not orally absorbed.

Cephalosporins are widely used in the Pediatric practice with a good tolerance (Powell 1991), even in the neonatal period, so it is very unlikely that in small amounts through milk would be a cause of problems in the infant.

Although rare, the possibility of transient gastroenteritis due to alteration of the intestinal flora in infants whose mothers take antibiotics should be taken into account (Benyamini 2005, Ito 1993).

Expert authors consider the use of this medication safe during breastfeeding (Hale, Lactmed, Briggs 2015, Schaefer 2015, Rowe 2013).

Alternatives

We do not have alternatives for Цефуроксим since it is relatively safe.

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.
DONATE NOW

Other names

Цефуроксим is Cefuroxime in Cyrillic.

Is written in other languages:

Цефуроксим is also known as

Groups

Цефуроксим belongs to these groups or families:

Tradenames

Main tradenames from several countries containing Цефуроксим in its composition:

Pharmacokinetics

Variable Value Unit
Oral Bioavail. 30 - 50 %
Molecular weight 424 daltons
Protein Binding 35 - 50 %
VD 0.33 l/Kg
pKa 3.15 -
Tmax 0.75 - 3 hours
T½ 1.1 - 1.5 hours
Theoretical Dose 0.22 mg/Kg/d
Relative Dose 1.3 - 2.6 %
Ped.Relat.Dose 0.2 %

References

  1. LactMed. Drugs and Lactation Database (LactMed). Internet. Bethesda (MD): National Library of Medicine (US); 2006-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK501922/ 2006 - Consulted on April 16, 2024 Full text (link to original source)
  2. Hale TW. Medications & Mothers' Milk. 1991- . Springer Publishing Company. Available from https://www.halesmeds.com Consulted on April 10, 2024 Full text (link to original source)
  3. Kiriazopoulos E, Zaharaki S, Vonaparti A, Vourna P, Panteri-Petratou E, Gennimata D, Lombardo K, Panderi I. Quantification of three beta-lactam antibiotics in breast milk and human plasma by hydrophilic interaction liquid chromatography/positive-ion electrospray ionization mass spectrometry. Drug Test Anal. 2017 Jul;9(7):1062-1072. Abstract
  4. Schaefer C, Peters P, Miller RK. Drugs During Pregnancy and Lactation. Treatment options and risk assessment. Elsevier, Third Edition. 2015
  5. Briggs GG, Freeman RK, Towers CV, Forinash AB. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. Wolters Kluwer Health. Tenth edition (acces on line) 2015
  6. Rowe H, Baker T, Hale TW. Maternal medication, drug use, and breastfeeding. Pediatr Clin North Am. 2013 Feb;60(1):275-94. Abstract
  7. Benyamini L, Merlob P, Stahl B, Braunstein R, Bortnik O, Bulkowstein M, Zimmerman D, Berkovitch M. The safety of amoxicillin/clavulanic acid and cefuroxime during lactation. Ther Drug Monit. 2005 Abstract
  8. Ito S, Blajchman A, Stephenson M, Eliopoulos C, Koren G. Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication. Am J Obstet Gynecol. 1993 May;168(5):1393-9. Abstract
  9. Powell DA, James NC, Ossi MJ, Nahata MC, Donn KH. Pharmacokinetics of cefuroxime axetil suspension in infants and children. Antimicrob Agents Chemother. 1991 Abstract Full text (link to original source) Full text (in our servers)
  10. Vree TB, Hekster YA. Pharmacokinetics and tissue concentrations of cefuroxime. Pharm Weekbl Sci. 1990 Abstract
  11. Nakamura T, Hashimoto I, Sawada Y, Mikami J. [Clinical studies on cefuroxime axetil in acute mastitis]. Jpn J Antibiot. 1987 Abstract
  12. Voropaeva SD, Emel'ianova AI, Ankirskaia AS, Minasova GS, Saakian SS. [Effectiveness of using cefuroxime in the obstetrics and gynecology clinic]. Antibiotiki. 1982 Abstract

Total visits

4,110

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 of United States of America

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM